R&D spending across the global pharmaceutical sector climbed 1.5% in 2024, according to unreleased data from Evaluate Pharma.

As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities ...

The startup is the latest beneficiary of investors’ appetite for protein-degrading technology, which offers a way to reach ...

Biogen and City Therapeutics, a privately held developer of RNA-based “trigger molecules,” announced a partnership to develop ...

As the World Health Organization initiates a new agreement for coordinating global responses to future pandemics, the future ...

It’s GlycoEra’s time to shine. The biotech has closed a series B fundraise clocking in at $130 million, with the funds set to ...

Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...